Decapeptyl SR 11.25mg Vial POM x1
In Stock
ℹ Please Note: We can only sell & ship Pharma items to registered medical professionals at registered medical premises.
If you are not Pharma approved, you should complete our
Online POM Form
and we will let you know when your account has been given Pharma Approval.
Powder and solvent for suspension for injection, sustained release formulation.
Therapeutic indications
• Treatment of patients with locally advanced, non-metastatic prostate cancer, as an alternative to surgical castration (see section 5.1).
• Treatment of metastatic prostate cancer.
• As adjuvant treatment to radiotherapy in patients with high-risk localised or locally advanced prostate cancer.
• As neoadjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced prostate cancer.
• As adjuvant treatment to radical prostatectomy in patients with locally advanced prostate cancer at high risk of disease progression.
• Treatment of endometriosis.
•Treatment of precocious puberty (onset before 8 years in girls and 10 years in boys).
Features
Nature and contents of container
• A type I, 4mL capacity glass vial with an elastomer stopper and an aluminium cap containing the powder.
• A type I, 3mL capacity glass ampoule containing 2mL of the suspension vehicle.
• Box containing 1 vial and 1 ampoule with 1 syringe and 2 needles.
Special precautions for storage
• Do not store above 25°C. Keep container in the outer carton.
Shelf life
• The product should be used immediately after reconstitution.
Patient Information Leaflet
https://www.medicines.org.uk/emc/files/pil.780.pdf
| Presentation | Vial |
| Presentation | Vial |
| Pack size | 1 |
| Presentation | Vial |